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Abstract 
Contagious caprine pleuropneumonia (CCPP), caused by Mycoplasma capricolum subsp. capripneumoniae is a 
severe disease widespread in Africa and Asia. Limited knowledge is available on the pathogenesis of this organism, 
mainly due to the lack of a robust in vivo challenge model and the means to do site‑directed mutagenesis. This work 
describes the establishment of a novel caprine challenge model for CCPP that resulted in 100% morbidity using a 
combination of repeated intranasal spray infection followed by a single transtracheal infection employing the recent 
Kenyan outbreak strain ILRI181. Diseased animals displayed CCPP‑related pathology and the bacteria could subse‑
quently be isolated from pleural exudates and lung tissues in concentrations of up to  109 bacteria per mL as well as 
in the trachea using immunohistochemistry. Reannotation of the genome sequence of ILRI181 and  F38T revealed the 
existence of genes encoding the complete glycerol uptake and metabolic pathways involved in hydrogen peroxide 
 (H2O2) production in the phylogenetically related pathogen M. mycoides subsp. mycoides. Furthermore, the expression 
of L‑α‑glycerophosphate oxidase (GlpO) in vivo was confirmed. In addition, the function of the glycerol metabolism 
was verified by measurement of production of  H2O2 in medium containing physiological serum concentrations of 
glycerol. Peroxide production could be inhibited with serum from convalescent animals. These results will pave the 
way for a better understanding of host–pathogen interactions during CCPP and subsequent vaccine development.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Contagious caprine pleuropneumonia (CCPP) is an 
important livestock disease that is widespread in the 
Middle East, Asia and Africa. Infection of goats with the 
causative agent Mycoplasma capricolum subsp. caprip-
neumoniae (Mccp)  causes pneumonia with respiratory 
symptoms that may progress into a lethal, generalized 
acute pleuropneumonia or to a chronic form with milder 
clinical signs and restricted pathomorphological lesions 
[1]. The infection is acquired through inhalation of con-
taminated droplets [2] and can cause morbidities and 
mortalities up to 100% and 80%, respectively [3]. Trans-
mission of M. capricolum subsp. capripneumoniae to 
wild ungulates such as Arabian Oryx and Tibetan ante-
lope has also been reported [4, 5]. Despite the fact that 
CCPP is on the list of diseases notifiable to the World 
Organization for Animal Health (OIE), only a few coun-
tries reported outbreaks between 2014 and 2018 (Fig-
ure  1). This might be due to lack of disease awareness, 
declining public funds to conduct surveillance and 
monitoring, suboptimal diagnostics and a possible mis-
perception of CCPP symptoms with other respiratory 
diseases such as “peste des petits ruminants” (PPR) or 
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Pasteurella spp. infections [6, 7]. During the last century, 
a bacterin-type of vaccine, co-formulating M. capricolum 
subsp. capripneumoniae type strain  F38T and saponin 
was developed for disease control in domestic goats [8]. 
Despite inducing immunity for up to 1 year, the use of a 
bactericidal adjuvant prohibits the inclusion of this vac-
cine in a combinatorial formula with live attenuated vac-
cines against additional caprine diseases such as PPR 
and capripox. The development of an efficacious vaccine 
formula against CCPP requires a robust and reproduc-
ible experimental challenge model [9]. Past infection 
models for CCPP include in-contact challenge [10–12], 
endobronchial inoculation [3, 12, 13] and intratracheal 
administration [10]. Although mimicking the natural 
disease transmission, in-contact experiments are often 
time-consuming, require a large number of animals and 
are difficult to standardize. The latter two infection meth-
ods are technically challenging and can result in different 
pathomorphological outcomes ranging from the absence 
of any clinical or pathomorphological changes to severe 
clinical disease and pathology [10, 13]. Consequently, 
an improved model to reproduce CCPP would not only 
enable vaccine efficacy studies but also foster in  vivo 
studies that provide insights regarding the molecular 
mechanisms associated with pathogenicity and the viru-
lence traits involved. The factors driving host–pathogen 
interactions in Mccp are not well understood. Hydrogen 
peroxide production, which is a candidate pathogenic-
ity mechanism in many pathogenic Mycoplasma [14] has 
not investigated in Mccp yet.
Here we describe the establishment of a novel in vivo 
challenge model for CCPP that will pave the way for 
future vaccine development and vaccine efficacy studies. 
We expect this novel model to enable the research com-
munity to decipher CCPP-pathogenicity mechanisms 
and to identify virulence traits in Mccp. In addition, we 
report on the functionality of the enzymatic pathway 
leading to hydrogen peroxide production in M. capri-
colum subsp. capripneumoniae.
Materials and methods
M. capricolum subsp. capripneumoniae culture conditions
Mycoplasma capricolum subsp. capripneumoniae 
ILRI181 was isolated during a recent CCPP outbreak in 
Kenya [15], while type strain  F38T [3] was kindly supplied 
by the African Union Pan African Veterinary Vaccine 
Figure 1 Presence of contagious caprine pleuropneumonia from 2014 to 2018 based on the World Animal Health Information Database. 
Countries displayed in red have the disease present and countries displayed in purple have the disease limited to one or more zones.
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Centre (AU-PANVAC), Ethiopia. Both strains were cul-
tured in mycoplasma liquid medium containing a phe-
nol-red pH indicator (Mycoplasma Experience Ltd, UK) 
at 37 °C under static conditions.
For the experimental challenges, M. capricolum subsp. 
capripneumoniae ILRI181  (2nd passage) was cultured as 
described above to early logarithmic phase for 24–48  h 
(pH ≥ 6.8), aliquoted and stored in liquid nitrogen until 
further use. The infectious dose (color changing units 
[CCU/mL]) was determined by serial dilutions of two 
frozen aliquots including two technical replicates. The 
dilutions were incubated for 7 days. A color change from 
red to orange/yellow was considered as growth and the 
CCU/mL were determined [7].
Production of polyclonal anti‑M. capricolum subsp. 
capripneumoniae antibodies
The polyclonal antibodies were custom developed by 
BioGenes GmbH, Germany. In brief, rabbits were immu-
nized intramuscularly with 200 µg heat-killed (100 °C for 
10  min) M. capricolum subsp. capripneumoniae  F38T 
mixed with BioGenes adjuvants. Animals were boosted 
with the same total antigen/adjuvant formula on day 7 
(100 µg), 14 (50 µg), 49 (50 µg), 63 (50 µg) and on day 70 
(50 µg) post initial immunization. Polyclonal serum was 
harvested on day 77 post-immunization. For preservation 
purposes, thimerosal was added to the sera to a final con-
centration of 0.02%. Samples were stored at −20 °C until 
further use.
Reannotation of the M. capricolum subsp. capripneumoniae 
ILRI181 and  F38T genome
The genomes of M. capricolum subsp. capripneumoniae 
ILRI181 and  F38T were reannotated (GenBank acces-
sion LN515399.1 and LN515398.1) using the Prokka 
pipeline [16] employing the previous draft genome [15], 
M. mycoides subsp. mycoides strain Afadé (GenBank 
accession LAEX00000000), type strain PG1 (GenBank 
accession NC_005364.2) and UniProtKB as additional 
databases.
Phylogenetic analysis of l‑α‑glycerophosphate oxidase 
(GlpO) among members of the “M. mycoides cluster”
Amino acid sequences of GlpO from M. capricolum 
subsp. capripneumoniae ILRI181 and  F38T [15], 1601 
[17], 9231-Abomsa [18], M. mycoides subsp. mycoides 
Afadé, B237 [19] PG1 [20], T1/44 [21] and Gladysdale 
[22], M. leachii  PG50T [22], M. capricolum subsp. capri-
colum  ATCC27343T (GenBank accession NC_007633) 
and M. feriruminatoris  G5847T [23, 24] (used as an out-
group) were retrieved from GenBank. Multiple align-
ments were generated using MUSCLE [25], curated 
from unreliable sites with Gblocks [26] and the phyloge-
netic tree was constructed by the Maximum Likelihood 
method using PhyML [27].
In silico analysis of the l‑α‑glycerophosphate oxidase 
(GlpO) among members of the “M. mycoides cluster”
Amino acid sequences from all the selected member of 
the Spiroplasma phylogenetic group were retrieved as 
described above. Cellular localization of each individ-
ual GlpO was predicted using PSORTb [28] using the 
advanced Gram stain setting “negative without outer 
membrane” dedicated to analyzing Mycoplasma spp. 
organisms. Transmembrane helices and signal pep-
tide cleavage predictions have been done using Phobius 
[29] and SignalP [30], respectively. SignalP prediction 
was done with “Gram-positive bacteria” as the organ-
ism group setting, as mycoplasmas lack the type I signal 
peptidase of Gram-negative bacteria used by the software 
to detect standard signal peptides for this group.
In silico analysis of the flavin‑adenine‑dinucleotide 
(FAD)‑binding site of GlpO
Amino acid sequences from the FAD-binding site of 
GlpO from M. capricolum subsp. capripneumoniae 
ILRI181 and l-2-hydroxyglutarate dehydrogenase 
(L2HDH) from several species e.g. bovine, goat, rabbit 
and mouse were obtained from various public databases; 
ENSEMBL [31], UniProtKB [32] and RCSB [33]. The 
sequence alignment was performed in MyHits [34] with 
MAFFT [35] defaults and viewed with Jalview [36]. The 
phylogenetic tree was calculated in Jalview with neigh-
bor-joining method using BLOSUM62 distance. The 
3D images were calculated in Chimera [37, 38] by align-
ing the structure of GlpO from Escherichia coli (2QCU) 
with GlpO peptide (DICIIGGGIIG) from M. capricolum 
subsp. capripneumoniae ILRI181.
Experimental challenge model
Experimental animals
The sample size (n = 10 animals) was determined based 
on an expected morbidity of 80% induced by M. capri-
colum subsp. capripneumoniae ILRI181. We can thus 
ensure that with a 95% confidence the true morbidity is 
at least 55% (lowest reasonable threshold) if we observe 
80% morbidity with 10 animals, using a 1-sample 2-sided 
exact calculation.
Ten outbred male goats (Capra aegagrus hircus), 
1–2  years of age, weighing between 12.5 and 30.5  kg, 
were utilized in this study. The animals were randomly 
selected from the ILRI ranch in Kapiti (a CCPP-free 
region in Kenya), had not previously been vaccinated 
against CCPP and were seronegative to M. capricolum 
subsp. capripneumoniae prior to challenge. The animals 
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were vaccinated against foot and mouth disease (FOTI-
VAX™, Kevevapi, Kenya) at the ILRI ranch on −44 days 
post-infection (dpi), transferred to the ILRI campus in 
Nairobi −30  dpi and kept in quarantine until −7  dpi. 
During the quarantine all animals were treated once for 
ectoparasites using Chlorpyrifos (500  g/L)/Cyperme-
thrin 50  g/L (Duodip 55% Norbrook Kenya Ltd, Kenya) 
and twice for helminths, −23 dpi and −2 dpi using Lev-
amisole Hydrochloride 3.0% w/v and oxyclozanide 6.0% 
w/v (Levafas Drench, Norbrook Kenya Ltd, Kenya) and 
Ivermectin 1% w/v (Noromectin, Norbrook, Kenya Ltd, 
Kenya) respectively, according to manufacturer’s recom-
mendations. All animals were then vaccinated against 
enterotoxaemia (Jovaclost T, Jovac, Jordan), sheep and 
goat pox (S&G Pox™, Kevevapi, Kenya), foot and mouth 
disease (FOTIVAX™, Kevevapi, Kenya), PPR (Pestivax, 
Kevevapi, Kenya) and anthrax & blackleg (Blanthax vac-
cine, Cooper, Kenya) on −22  dpi, −16  dpi and −9  dpi, 
respectively. One week before the experimental infection, 
10 goats were transferred to the animal biosafety level 
two (ABSL2) facility where they were all housed together 
for the remainder of the study. The animals were allowed 
to move freely within the ABSL2 room (28 m2 with saw-
dust bedding), had water, hay, and mineral lick ad  libi-
tum and received a portion of pellets in the morning 
(after the clinical examination) and in the afternoon. The 
animals were monitored twice daily (and on additional 
time points as needed) by a veterinarian and any medi-
cal concerns were addressed immediately. The study was 
conducted with animal welfare a high priority. Addition-
ally, we included a mock-infected control group of three 
female and two male goats (CM233, CM251, CM253, 
CM260 and CM261) derived from the same population 
as the other animals and treated as described above.
Study design and experimental procedures
Ten goats were infected twice intranasally on two consec-
utive days (0 and 1 dpi) and once transtracheal by needle 
puncture, 5–10 cm caudal to the larynx (4 dpi). For the 
intranasal aerosol infection, thawed M. capricolum subsp. 
capripneumoniae ILRI181 liquid cultures  (108 CCU/mL), 
prepared as described above, were aspirated into a 1 mL 
syringe with attached atomizer (MAD Nasal™ Intranasal 
Mucosal Atomization Device,  Teleflex®, UK) and each 
animal received 1 mL (500 µL/nostril) per infection. The 
final transtracheal infection was performed by admin-
istering 1  mL of culture  (108  CCU) followed by flush-
ing with 5 mL of sterile phosphate buffered saline (PBS). 
Infectious material from all three challenges was serially 
diluted as described above to confirm the CCU. In addi-
tion to assessing behavior and appetite, the animals were 
closely monitored for any adverse reactions (at the site 
of nasal and transtracheal administration) and clinical 
signs of infection. Rectal temperature, blood oxygen satu-
ration (measured at ear level), heart rate and breathing 
frequency were measured using a M750 digital thermom-
eter (GLA Agriculture Electronics, USA), VE H100B Vet-
erinary Pulse Oximeter (Edan, USA) and a stethoscope 
Classic II (Littmann, USA), respectively. Blood samples 
(taken by jugular vein puncture) and nasal swabs were 
taken twice per week starting 3  days before infection. 
The weight (kg) of the animals was measured once per 
week or daily at signs of clinical disease. Animals show-
ing either a rectal temperature > 40.5  °C for > 3 consec-
utive days, signs of moderate to severe pain or distress, 
weight loss > 10% within 7 days or a breathing frequency 
of > 50/min for > 3  days were euthanized via intrave-
nous injection of Sodium Pentobarbitone [220  mg/mL, 
Eutha-naze Injection, Bayer (Pty) Ltd Animal Health Div, 
South Africa] at a dosage of 100 mg/kg body weight. The 
remaining animals were euthanized 31  days post-infec-
tion (dpi). The mock-infected group was treated as above 
but received Mycoplasma medium without infectious 
agent. The mock-infected group was euthanized 35 dpi.
Hematological parameters
EDTA blood from Mccp-infected animals was used to 
measure the white blood cell (WBC) and red blood cell 
(RBC) count using the Celltac α MEK-6450 (Nihon Koh-
den, Japan). For caprine blood samples the parameters in 
the settings menu were adjusted as follows: WBC sen-
sitivity = 10, WBC threshold = 7, RBC sensitivity = 15, 
RBC threshold: 3, RBC AUTO = OFF, PLT threshold = 5. 
The blood samples were thoroughly mixed with an equal 
volume of buffer (ISOTONAC 3, Nihon Kohden, Japan) 
prior to measurement. Provided values for WBCs, RBCs, 
HGB (hemoglobin) and HCT (hematocrit) were doubled 
prior to analysis to account for the buffer dilution. The 
analysis was carried out using the QP-821V Data Man-
agement Software LITE (Nihon Kohden, Japan).
Post‑mortem analysis
Extensive post-mortem examinations were performed 
according to standard procedures [39]. Urine samples 
(1–2 mL per animal) taken at necropsy via needle punc-
ture of the bladder were stored at −80  °C. When avail-
able, pleural fluid and lung juice (collected from a lung 
cut section) were collected and stored at −80  °C until 
further use. Fresh tissue samples of trachea and lung 
(different gross pathological lesions and unremarkable 
areas), heart, intestine, liver, kidney, spleen and several 
lymph nodes (retropharyngeal, prescapular, tracheal, 
peribronchial, mediastinal and mesenteric) were imme-
diately fixed in a ready to use zinc formalin fixative solu-
tion (Sigma-Aldrich, USA) for 48 h at room temperature, 
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transferred into 10% buffered formalin and subsequently 
embedded in paraffin for histological analysis.
Histology and immunohistochemistry
Paraffin-embedded tissue sections of 4  µm in thickness 
were stained with hematoxylin and eosin (HE) for his-
topathological evaluation. For immunohistochemistry 
(IHC), 4 μm sections were mounted on positively charged 
glass slides  (Superfrost®plus, Thermo Scientific, Ger-
many). After deparaffinization, rehydration and antigen 
retrieval (95  °C for 30  min), rabbit anti-M. capricolum 
subsp. capripneumoniae (used at 1:3000 dilution) stains 
were performed using an automated immunostainer 
Leica Bond RX (Leica Biosystems, Switzerland). Visu-
alization was facilitated using the Bond Polymer Refine 
Detection kit (Leica Biosystems, Switzerland) according 
to the manufacturer’s instructions.
Serology
Antibody titers against M. capricolum subsp. capripneu-
moniae were determined in sequential serum samples 
using the IDEXX CCPP Ab Test (IDEXX, France) [6] 
according to the manufacturer’s instructions.
Quantification of the hydrogen peroxide production 
 (H2O2) of M. capricolum subsp. capripneumoniae 
in vitro and testing of the potential inhibitory effect 
by convalescent goat serum
To measure the production of hydrogen peroxide, M. 
capricolum subsp. capripneumoniae ILRI181 was grown 
as described above for about 26  h to end-exponential 
growth, when pH ≥ 6.9 and a density of approximately 
 107–108 CCU/mL was reached. Triplicate 1 mL cultures 
were taken for DNA extraction and another 1  mL ali-
quot for use in the hydrogen peroxide assay. DNA was 
extracted as described previously [40] and concentrations 
were measured using a Nanodrop 2000c spectrophotom-
eter (Thermo Scientific, USA). For the peroxide assay, 
culture aliquots were centrifuged at 8000 × g for 10 min 
at 4  °C, washed once in cold PBS (4  °C, pH 7.3), centri-
fuged again and resuspended in pre-warmed PBS (37 °C). 
The suspensions were subsequently incubated at 37  °C 
for 1 h with serum from convalescent goats (decomple-
mented [56 °C for 30 min] and diluted 1:20, collected on 
−3 and 31  dpi), prior to centrifugation at 8000 ×  g for 
10  min at 37  °C, washed twice in pre-warmed PBS and 
resuspended in pre-warmed reaction buffer (provided 
in the kit described below). To induce  H2O2 production, 
glycerol was added to the suspensions at a final concen-
tration of 100  µM (the physiological concentration in 
caprine serum). Neat suspensions of ILRI181 only, with 
and without glycerol were included as a positive and 
negative control respectively. The production of  H2O2 
was measured using the Amplex Red Hydrogen Peroxide/
Peroxidase Assay Kit (Life Technologies, UK) accord-
ing to manufacturer’s instructions. Briefly, 50 μL of each 
sample was gently mixed with 50 μL of the Amplex Red 
reagent in opaque black 96-well plates  (Costar®, Corning 
Incorporated, USA). Fluorescence was measured after a 
30 min incubation using a Synergy HT microplate reader 
(BioTek, US) with excitation and emission set at 530 nm 
and 590  nm, respectively. A standard curve for  H2O2 
concentrations (provided in the kit) was included in the 
assay. Four technical replicates were performed for each 
sample and the assay repeated three times. The results 
were normalized against the DNA concentration. To ena-
ble a paired t-test comparing all pre- and post-infection 
samples, a 2-way ANOVA was initially used to check for 
differences in the change in response, pre- vs. post-infec-
tion, between animals (n = 4) and runs (times the experi-
ment was repeated, n = 3).
Western blot analysis for in vivo detection of GlpO
Western blot analyses were performed as described pre-
viously [41] but with the following modifications. Pleu-
ral fluid samples (1 mL) were centrifuged at 21 130 × g 
for 20 min prior to resuspension in PBS, lysis (99 °C for 
10  min) and separation by 12% SDS PAGE. Gels were 
stained with Coomassie or transferred to nitrocellulose 
membranes (GE Healthcare Life Science) for Western 
blots. The membranes were blocked with 5% skimmed 
milk overnight at 4  °C prior to incubation with the pri-
mary antibody (rabbit IgG anti-GlpO), used at 1:100 dilu-
tion [42], for 1 h at room temperature. The membranes 
were subsequently incubated with horseradish peroxi-
dase-conjugated secondary antibodies (anti-rabbit IgG 
[Sigma-Aldrich, USA] used at 1:1000 dilution) for 1 h 
at room temperature prior to adding the TMB substrate 
(Pierce™, Thermo Scientific, USA). M. capricolum subsp. 
capripneumoniae ILRI181,  F38T and M. mycoides subsp. 
capri GM12 cultures were included as positive controls.
Bacteriology
For detection of live M. capricolum subsp. capripneumo-
niae serial dilutions (up to  10−12) were made from pleu-
ral fluid and lung juice in standard mycoplasma medium 
(Mycoplasma Experience Ltd, UK). The dilutions were 
cultured as described above and the CCU/mL were 
determined. When needed, lung tissue cultures were per-
formed. In addition, nasal swabs were taken throughout 
the experiment and whole blood (taken prior to eutha-
nasia), carpal joint fluid and urine collected at post-
mortem were cultured in a 1:10 dilution. The presence of 
M. capricolum subsp. capripneumoniae was confirmed 
directly from culture material using a specific recombi-
nase polymerase amplification (RPA) assay as described 
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previously [7]. The pH of the urine was measured on 
thawed specimens using a total of three different pH test 
strips with overlapping range coverages (Fluka, Switzer-
land; Merck, Germany; Sigma, USA).
Transmission electron microscopy
Regions of interest in lung tissue samples were selected 
based on pathological changes seen in corresponding 
paraffin sections and immunopositive staining with the 
anti-M. capricolum subsp. capripneumoniae antibody. 
Corresponding tissue areas were punched out from par-
affin blocks, dewaxed in Neoclear (Merck, Switzerland) 
twice for 10 min, rehydrated through a descending eth-
anol series and transferred to 0.1  M cacodylate buffer 
(dimethylarsinic acid sodium salt trihydrate; Merck, 
Switzerland). Samples were post-fixed with 1% osmium 
tetroxide  (OsO4, Polysciences, USA) in 0.1 M cacodylate 
buffer for 2  h at room temperature. After three washes 
in cacodylate buffer, the tissues were dehydrated again 
through an ascending ethanol series and transferred to 
acetone four times for 30 min each. Infiltration was car-
ried out with mixtures of acetone/Epon (FLUKA, Swit-
zerland) at ratios of 3:1 and 1:1 respectively, for 3 h each 
at room temperature. Samples were left in acetone/Epon 
at a ratio of 1/3 overnight at 4  °C, transferred to pure 
Epon and polymerized at 60 °C for 5 days. Semi-thin sec-
tions of 0.5 µm in thickness were stained with toluidine 
blue and used to localize areas of interest. Resin blocks 
were trimmed accordingly and ultrathin sections exhib-
iting silver interference were produced with diamond 
knives (Diatome, Switzerland) on a Reichert-Jung Ultra-
cut E ultramicrotome (Leica, Switzerland). Ultrathin 
sections were collected on collodion-coated 200 mesh 
copper grids (Electron Microscopy Sciences, USA). Sec-
tions were then double-stained with 0.5% uranyl acetate 
(Sigma-Aldrich, Germany) for 30  min at 40  °C and 3% 
lead citrate (Leica, Switzerland) for 10  min at 20  °C in 
an  Ultrastain® (Leica, Austria) and examined in a Philips 
CM12 transmission electron microscope (FEI, Holland) 
at an accelerating voltage of 80  kV. Micrographs were 
captured with a Mega View III camera using the iTEM 
software version 5.2 (Olympus Soft Imaging Solutions 
GmbH, Germany).
Results
Reannotation of the genome of M. capricolum subsp. 
capripneumoniae ILRI181 and  F38T
Reannotation of the genome of M. capricolum subsp. 
capripneumoniae ILRI181 and  F38T revealed the pres-
ence of gene glpO (locus tags: MCCPF38_00276 and 
MCCPILRI181_00272) upstream of glpK (encoding glyc-
erol kinase). Gene glpO was originally miss-annotated as 
lhgO (2-hydroxyglutarate oxidase) by automatic genome 
annotation. Furthermore, the genes gtsABC (locus tags: 
MCCPF38_00541-3 and MCCPILRI181_00539-41) 
encoding the active ATP-dependent glycerol uptake sys-
tem [43] were also identified.
Phylogenetic relationship of GlpO among members 
of the “M. mycoides cluster”
The phylogenetic relationship of GlpO among members 
of the “M. mycoides cluster” corresponds to the general 
phylogenetic relationship based on house-keeping genes 
[44] with the exception of GlpO from M. leachii which is 
related more to GlpO from M. mycoides subsp. mycoides 
than to M. mycoides subsp. capri (Figure 2). M. mycoides 
have been shown to produce peroxide. Therefore, we 
tested the ability of Mccp to produce peroxide in the 
presence of glycerol (see below).
In silico characterization of GlpO among members 
of the “M. mycoides cluster”
All amino acid sequences available for this cluster were 
used to improve characterization of the GlpO cellular 
localization. No evidence of transmembrane helices was 
found using Phobius and no cleavage sites for signal pep-
tides were identified. In addition, all sequences were pre-
dicted to be cytoplasmic with a score of 7.5 (out of 10).
Flavin‑adenine‑dinucleotide (FAD)‑binding site of GlpO
Since the goat proteome was not available at the time 
that this research was undertaken, we used the bovine 
proteome to search for homologies to the GlpO amino 
acid sequence. A small conserved region at the N-termi-
nus of the protein was found, that displays similarities to 
a region of the mitochondrial l-2-hydroxyglutarate dehy-
drogenase (UniProtKB:A7MBI3) at the beginning of the 
FAD-binding domain in both proteins. Using ENSEMBL 
Mmc GM12
M. leachii PG50T
Mmm Gladysdale
Mmm PG1T
Mmm Afadé
Mmm B237
Mmm T1/44
Mccp 9231-Abomsa
Mccp M1601
Mccp F38T
Mccp ILRI181
Mcc ATCC27343T
M. feriruminatoris G5847T
0.93
0.96
0.76
0.98
0.92
0.82
0.02
Figure 2 Phylogenetic tree based on the GlpO amino acid 
sequences of “M. mycoides cluster” members. The GlpO sequence 
of M. feriruminatoris was used as an outgroup. Bootstrap values are 
displayed. Mcc: Mycoplasma capricolum subsp. capricolum; Mccp: 
Mycoplasma capricolum subsp. capripneumoniae, Mmc: Mycoplasma 
mycoides subsp. capri; Mmm: Mycoplasma mycoides subsp. mycoides. 
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we identified orthologues to this L2HGDH gene in the 
goat genome and in other relevant species. A multiple 
sequence alignment was performed, and a single valine/
isoleucine substitution was identified (Additional file 1). 
Furthermore, the M. capricolum subsp. capripneumoniae 
region was aligned to the 3D structure of E. coli GlpO 
(rcsb:2QCU) (Additional file 1) showing that the valine/
isoleucine residue is located near to the FAD-binding 
site, although it does not look critical for FAD binding.
Experimental in vivo challenge
Disease progression
Ten male goats (CK042, CM043, CM048, CM049, 
CM124, CM145, CM166, CM180, CM186, and CM189) 
were experimentally infected by an intranasal spray 
(0 and 1  dpi) and transtracheal injection (4  dpi) using 
live M. capricolum subsp. capripneumoniae ILRI181 
 (108 CCU/mL/dose) (Additional file 2). Culturing of the 
remaining infectious material post-challenge confirmed 
titers of  108  CCU/mL. No adverse reactions were seen 
at nasal or neck level throughout the study period. All 
animals developed pyrexia (defined as rectal tempera-
tures > 39.5 °C) between 7 and 14 dpi with temperatures 
ranging from 39.6 to 41.4 °C (Additional file 3). The dura-
tion of fever varied between individual animals between 
3 and 6 days. Concurrent with pyrexia, a majority of the 
animals developed a persistent cough (n = 7), with the 
highest number of coughing animals recorded between 
9 and 12  dpi (Figure  3). Laborious and rapid breathing 
(breathing frequency of > 50/min) was documented in five 
animals (CK042, CM049, CM124, CM186, and CM189) 
coinciding with the peak of pyrexia (12  dpi, Additional 
file  3). Clinical disease was also associated with weight 
loss (Additional file 3) and six of ten animals experienced 
a drastic weight reduction of > 10% within 7 days. Addi-
tional sporadically observed clinical features included 
repeated sneezing, shivering, teeth grinding, ruffled/dull 
fur coat and diarrhea. Clinical disease was also associated 
with behavioral changes such as seeking solitude and 
standing with the head down. The above mentioned clini-
cal features resembled textbook reports of CCPP [45]. 
Blood oxygen saturation always remained above 97% 
for all animals throughout the course of the study (data 
not shown). Six goats (CK042, CM049, CM124, CM180, 
CM186, and CM189) were euthanized between 12 and 
17 dpi due to the severity of disease. The remaining ani-
mals, were euthanized at the end of the study period, 
31  dpi. All five mock-infected goats (CM233, CM251, 
CM253, CM260 and CM261) were clinically healthy 
throughout the study period (Additional file 3).
Hematology
There was a marked increase in white blood cell count 
(WBC,  103/μL) after 18  dpi (Additional file  4) in three 
out of four goats that got infected with Mccp and sur-
vived. The counts had however dropped to pre-infection 
level by 25 dpi. The red blood cell counts (RBC,  106/μL) 
showed great fluctuations for all animals from 7 dpi until 
the end of the study (Additional file 4). As expected, the 
hemoglobin (HGB, g/dL) and hematocrit (HCT, %) fol-
lowed the fluctuating pattern of the RBC counts (Addi-
tional file 4).
Pathological observations
Post-mortem examination showed the presence of 
CCPP-typical macroscopic lesions in the lungs of all 
Mccp-infected animals (examples are given in Additional 
file 5), confirming successful experimental infection. Dif-
ferent pathological patterns of fibrinous bronchopneu-
monia were recorded; fibrinous adhesions, abundant 
fibrinous pleural effusion, lung consolidation, areas of 
coagulative necrosis and sequestra (Table 1). In six Mccp-
infected animals the lesions affected both lungs, mainly 
involving apical, cardiac and accessory lobes and only 
rarely extending to the diaphragmatic lobes. The right 
lung was always affected. In animal CM180 with severe 
fibrinous bronchopneumonia, we also observed acute 
white infarcts in the kidney (Additional file 5). Histopa-
thology revealed lesions of fibrinous bronchointersti-
tial pneumonia with pleuritis (pleuropneumonia) in the 
acute stage (Figures 4C and D). There were multiple areas 
of chronic lesions, i.e. abscess formation, pleural fibrosis 
and bronchiolitis obliterans (Figures  4E  and F), leading 
to the overall diagnosis of chronic-active pleuropneu-
monia (Table  2). Immunohistochemistry for M. capri-
colum subsp. capripneumoniae showed strong positivity 
in the area of severe, acute inflammation, in close con-
tact with or within alveolar neutrophils and macrophages 
in the alveoli (Figure  4H). A diffuse positive signal was 
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detected within the ciliated epithelial cells of the tra-
chea (Figure  4G). Typology, extension and lesion sever-
ity varied among the animals with severe lesions being 
more frequently observed in the animals that succumbed 
to disease than in recovering animals. No macroscopic 
or histopathological lesions were recorded in the mock-
infected animals.  
Serological responses to M. capricolum subsp. 
capripneumoniae
In the Mccp-infected group, seroconversion started from 
11 dpi and by 14 dpi, all surviving animals had positive 
responses that remained above cutoff throughout the 
study period (Additional file 6). The six animals that were 
euthanized due to disease severity were serologically neg-
ative. The mock-infected goats remained seronegative for 
Mccp throughout the experiment (Additional file 6).
Ability of the post‑infection sera to block  H2O2 production 
of M. capricolum subsp. capripneumoniae in vitro
In the presence of caprine serum concentrations of glyc-
erol (100  µM), M. capricolum subsp. capripneumoniae 
ILRI181 released on average 9.9 nM  H2O2/ng DNA after 
30 min of incubation (Figure 5). A significant reduction 
in the production was observed in the presence of post-
infection sera as compared to pre-infection sera p < 0.001 
(t11 = 5.17) (Figure  5). This corresponds to an average 
reduction of 4.022 nM  H2O2/ng DNA (95% CI 2.31, 5.73). 
Minimal  H2O2 release was observed in the control prepa-
rations containing mycoplasma and incubation buffer 
only.
In vivo detection of GlpO
Western blot analysis of pleural fluid samples collected 
at post-mortem revealed a positive signal at a size of 
about 42–43  kDa in four of the seven included animals 
(Additional file  7) using the rabbit IgG anti-GlpO anti-
body [42]. Pure cultures of M. capricolum subsp. caprip-
neumoniae ILRI181, F38 and M. mycoides subsp. capri 
GM12 had a similar band profile.
Isolation of M. capricolum subsp. capripneumoniae
Mycoplasma capricolum subsp. capripneumoniae was 
isolated from pleural fluid and/or lung juice from all but 
one of the Mccp-infected animals with titers reaching 
 109–1010 CCU/mL (Table 3). Goat CM043 showed mini-
mal clinical symptoms, very mild pathological lesions 
and samples from this animal, including lung tissues, 
were negative. Furthermore, whole blood taken prior 
to euthanasia and urine collected at post-mortem from 
the ten Mccp-infected animals were all culture nega-
tive and only one of the carpal joint fluid cultures (from 
animal CM124) was positive. Biweekly nasal swabs were 
occasionally positive in the Mccp-infected animals; ani-
mals CK042, CM049, and CM124 had positive swabs 
on 11  dpi, while animal CM048 had positive swabs on 
11 and 18 dpi. The urine from the six animals that were 
euthanized during the acute phase of the disease had an 
average pH of 6.4 (± 0.26) whereas that of the four ani-
mals that recovered from the acute stages and the mock-
infected animals had an physiological average pH of 8.5 
(± 0.2) (Additional file 8).
Transmission electron microscopy
In spite of the suboptimal tissue preservation and previ-
ous paraffin embedding, mycoplasmas were identified in 
Table 1 Characterization of pulmonary lesions in Mycoplasma capricolum subsp. capripneumoniae-infected goats 
Mock-infected animals are not displayed, since they did not have any lesions.
RA: right apical lobe, RC: right cardiac lobe, RD: right diaphragmatic lobe, AL: accessory lobe, LA: left apical lobe, LC: left cardiac lobe, LD: left diaphragmatic lobe.
Animal ID Day 
of euthanasia
Lung portion affected Consolidation Coagulative 
necrosis
Sequestra (Ø in cm) Pleural 
adhesions
Fibrinous 
adhesions
Pleural 
fluid 
(mL)
CK042 13 RA/C LC Red/grey + − − + 68
CM043 31 RA/C/D LC − − − + − −
CM048 31 RA Red − Multiple (0.3–0.5) − − −
CM049 12 RA/C/D AL LA/C Red/grey + − − + 100
CM124 12 RA/C Red/grey + − − + 170
CM145 31 RA/C − − 1.0 + − 3
CM166 31 RC − − 2.0 + − −
CM180 17 RA/C LA/C/D Red/grey + − − + 150
CM186 12 RA/C/D LA/C/D Red/grey + − − + 35
CM189 13 RA/C/D AL LA Red/grey + − − + 30
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Figure 4 Representative histopathological images (A–F) and immunohistochemistry (IHC) stainings (G–H) of caprine respiratory tissues. 
Tissues are derived from goats experimentally infected with Mycoplasma capricolum subsp. capripneumoniae (C–F) and from a mock‑infected 
control group (A, B no histopathological lesions present). C, D Lesions of the acute form of contagious caprine pleuropneumonia; airways filled with 
neutrophilic granulocytes (asterisk), edema, hemorrhage and fibrinoid degeneration and necrosis of vascular wall (arrow). E, F Lesions of the chronic 
form of CCPP; abscess formation with central coagulative necrosis and fibrous encapsulation (arrow) and the beginning of bronchiolitis obliterans in 
a bronchiole (clover). G Mycoplasma capricolum subsp. capripneumoniae‑positive IHC staining on apical cell border of ciliated respiratory epithelial 
cells in the trachea. H Mycoplasma capricolum subsp. capripneumoniae‑positive IHC staining in alveoli associated with neutrophilic granulocytes 
infiltration. Size standards are displayed in the lower right corner of each picture: A = 1 mm; B = 200 µm, C = 200 µm, D = 50 µm, E = 1 mm; 
F = 100 µm; G + H = 20 µm.
Page 10 of 15Liljander et al. Vet Res           (2019) 50:10 
electron micrographs of lung tissue based on morpho-
logical criteria such as their size (0.1–0.2 µm × 1–2 µm), 
pleomorphic shape and the single, trilayered membrane 
(Figures 6A and B).
Discussion
Here we report on the development of a new caprine 
challenge model for contagious caprine pleuropneumo-
nia (CCPP) that can be applied in resource-limited envi-
ronments, common in many low and middle-income 
countries (LMIC). As repeated contact is required for the 
transmission of many mycoplasmal diseases the method 
developed here incorporates recurring exposure to the 
causative agent M. capricolum subsp. capripneumoniae. 
Ten male goats were experimentally infected via two 
intranasal spray applications followed by a total tran-
stracheal deposit of 3 × 108 color changing units (CCU). 
This approach was considered safe as no adverse reac-
tions were seen at either site of inoculation. Moreover, 
to assure a defined inoculum of live mycoplasma, frozen 
aliquots (−80  °C) with a predetermined bacterial titer 
were used as already reported for M. mycoides subsp. 
mycoides [46]. The challenge dose used here is rather low 
compared to previous experimental M. mycoides subsp. 
mycoides and M. capricolum subsp. capripneumoniae 
infections where doses of  109–1010 mycoplasma have 
been used [47–50], yet, morbidity and mortality rates of 
100% and 60% respectively, were achieved. The inoculum 
applied in this experiment is however high compared to 
recent experimental M. bovis infections in calves where 
infection doses of 4 × 104 CCU/animal were administered 
in aerosol chambers [51]. On the other hand, infectious 
doses based on color changing units (CCU) might not be 
100% comparable between different mycoplasma species. 
Nevertheless, since we opted for a challenge model that 
can be easily applied in LMIC, we strongly believe that 
this challenge model is well suited since it does not rely 
on tailor-made equipment and can even be applied under 
field settings. While our novel challenge model resulted 
Table 2 Acute and chronic histopathology lesions observed in lung samples of Mycoplasma capricolum subsp. 
capripneumoniae-infected goats 
Mock-infected animals are not displayed, since they did not show any lesions.
a Histopathological criteria for acute stage of pneumonia.
b Histopathological criteria for chronic stage of pneumonia.
c Stages according to time of inflammation and adjacent reaction and regeneration mechanisms: A: acute, CA: chronic-active.
Animal ID Purulent 
 exudatea
Coagulative 
 necrosisa
Fibrinoid 
degeneration 
and necrosis 
of vessels/
vasculitis, 
 thrombosisa
Distended 
interlobular 
septae 
by edema 
and  fibrina
Perivascular 
lymphocytic 
 cuffinga, b
Pulmonary 
 abscessb
Bronchiolitis 
 obliteransb
Pleural 
 fibrosisb
Stage 
of  pneumoniac
CK042 + + + + + − − − A
CM043 + + − − + − + + CA
CM048 + + − − + + + + CA
CM049 + + + + + − − − A
CM124 + + + + − − − + CA
CM145 + + + − + + − + CA
CM166 + + + + + + + + CA
CM180 + + + + + − − + CA
CM186 + + + + + − − + CA
CM189 + + + + + − + + CA
p<0.001
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Figure 5 Production of hydrogen peroxide by M. capricolum 
subsp. capripneumoniae ILRI181. Pre‑infection (left) and 
post‑infection (right) sera from goats that recovered from a course 
of experimental contagious caprine pleuropneumonia were added 
to the medium. Error bars represent standard deviations from three 
biological replicates.
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in 60% of the animals reaching the endpoint criteria, we 
did not alter the titer of the challenge dose, which ret-
rospectively would have been desirable to determine a 
possible correlation of clinical disease, pathology and 
infectious dose. Nevertheless, all experimentally infected 
animals developed clinical signs, displaying elevated body 
temperatures (> 39.5°) with onset 7–14 dpi. Acute disease 
was characterized by high fever (> 40.5°, n = 8), a frequent 
and persistent cough (n = 7), rapid breathing (> 50/min, 
n = 5) and swift weight loss (n = 6). In addition, six ani-
mals had to be euthanized prior to the envisioned end of 
the study due to disease severity.
The attributes of virulence of strain ILRI181 result-
ing in this elevated pathogenicity remain unknown. 
However, the absence of a high number of passages and 
the relatively low numbers of generations that strain 
ILRI181 has been grown in axenic medium since its 
primary isolation might explain its superior patho-
genicity compared to other strains [52], despite the 
overall clonal structure of the species [44, 53, 54]. True 
reproduction of infection was confirmed by the suc-
cessful isolation of mycoplasmas from all but one ani-
mal, with high concentrations detected in lung juice 
and pleural fluid samples (Table 3) and the absence of 
clinical and pathomorphological changes in the five 
mock-infected animals. In addition, the presence of 
mycoplasmas in lung tissue was confirmed by immu-
nohistochemistry (Figure  4). Unexpectedly, M. capri-
colum subsp. capripneumoniae were also detected in 
the trachea (Figure 4E), likely as a result of the mucocil-
iary clearance, the expulsion of mycoplasma from the 
lung via coughing or from local colonization. Muco-
ciliary colonization has previously been described for 
other mycoplasmas such as M. hyopneumoniae [55]. 
The colonization of the upper respiratory tract by M. 
capricolum subsp. capripneumoniae might explain 
the higher infectivity compared to M. mycoides subsp. 
mycoides [56], which has not been reported to colonize 
the trachea in vivo [46, 47]. Future studies should focus 
on investigating a potential colonization of the epithe-
lial cells in the upper respiratory tract in order to char-
acterize any local cytotoxicity.
The mechanism associated with the pathogenesis seen 
during CCPP remain largely unknown and common 
bacterial virulence factors have not been found in the 
mycoplasma genome [20]. Here, the presence of the can-
didate mycoplasma virulence factor, GlpO, the enzyme 
Table 3 Results of culture and molecular identification 
of M. capricolum subsp. capripneumoniae from biological 
samples 
Mock-infected animals are not displayed, since Mycoplasma capricolum subsp. 
capripneumoniae was not detected in any of their specimens.
n/a: not analyzed, CCU/mL: color changing units per milliliter, RPA: recombinase 
polymerase amplification.
a Euthanized before 31 dpi.
Animal ID Pleural fluid Lung juice
CCU/mL RPA CCU/mL RPA
CK042a 106–107 Positive 109 Positive
CM043 n/a n/a n/a n/a
CM048 n/a n/a 104–105 Positive
CM049a 102–104 Positive n/a Positive
CM124a 109–1010 Positive 108 Positive
CM145 Negative Negative 103 Positive
CM166 n/a n/a 105 Positive
CM180a 109 Positive 109–1010 Positive
CM186a 109 Positive 106 Positive
CM189a 102–103 Positive 109 Positive
Figure 6 Electron micrographs of mycoplasma cells in caprine lung tissue. Mycoplasma cells are indicated by arrows. Scale bars: A (5 μm), B 
(1 μm).
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involved in the generation of  H2O2 during the oxidation 
of glycerol-3-phosphate, was investigated [14, 57–59]. 
The glpO gene has so far not been found in the genome of 
M. capricolum subsp. capripneumoniae F38 and ILRI181 
by automatic annotation [15]. However, our reannotation 
of the genome sequence of M. capricolum subsp. caprip-
neumoniae did indeed reveal the presence of the genes 
encoding the biologicals capable of assimilating glycerol 
added to the media at physiological concentrations, and 
to metabolize it to dihydroxyacetone phosphate with the 
release of toxic  H2O2. The in vivo expression of GlpO was 
also confirmed in pleural fluid from diseased animals 
(Additional file 7). The in vitro  H2O2 production was sig-
nificantly reduced, when Mccp cells were incubated with 
serum from convalescent goats, taken 31 dpi (Figure 5). 
It has however previously been shown that cattle immu-
nized with recombinant GlpO from M. mycoides subsp. 
mycoides failed to generate neutralizing antibodies and 
succumbed to disease after subsequent challenge, this 
despite mounting GlpO-specific antibodies [60]. The ina-
bility to raise a neutralizing humoral immune response to 
GlpO was hypothesized to be due to the high similarity of 
the flavin-adenine-dinucleotide (FAD)-binding site, one 
of the main active sites of GlpO from M. mycoides subsp. 
mycoides to the bovine FAD-binding site, but not murine 
or rabbit l-2-hydroxyglutarate dehydrogenase (L2HDH) 
[60]. Indeed, the same single amino-acid substitution was 
also identified in goats (Additional file 1). The reduction 
in  H2O2 seen between samples taken pre- and post-infec-
tion is indicative of the presence of antibodies inhibiting 
peroxide production. This is likely due to the fact that 
in the current study, goats were experimentally infected 
with live wild-type M. capricolum subsp. capripneumo-
niae, and hence are likely to have mounted antibodies 
against different epitopes of GlpO and against many other 
Mycoplasma components linked to the glycerol metabo-
lism. However, following our in silico analysis on all the 
different GlpO amino acid sequences retrieved among 
the members of the “M. mycoides cluster”, we could not 
identify any transmembrane domains or signal peptides. 
Therefore, all sequences were predicted to be cyto-
plasmic. This is in agreement with wet laboratory data 
obtained for M. pneumoniae [57] and for M. mycoides 
[61, 62] but in contradiction with previous scanning elec-
tron microscopy photographs on M. mycoides subsp. 
mycoides [42]. A cytoplasmatic localization would sup-
port the inability to produce neutralizing antibodies 
against GlpO, since they simply cannot reach its target. 
Based on these results, we anticipate that mutagenesis of 
the key enzymes involved in glycerol metabolism might 
attenuate M. capricolum subsp. capripneumoniae. This 
will be tested in future studies that aim to develop a live 
vaccine against CCPP. In conclusion, the establishment of 
an easy to use challenge model will foster the scientific 
efforts towards a better understanding of CCPP, which 
not only has a high impact on goats but also on the life of 
many livestock-dependent people in LMIC.
Additional files
Additional file 1. In silico analysis of the flavin‑adenine‑dinucleotide 
(FAD)‑binding site of L‑α‑glycerophosphate oxidase (GlpO). A) Mul‑
tiple sequence alignment of the L2HGDH peptide from several species 
colored with Jalview according to ClustalX schema. The sequence names 
are colored according to the tree split (vertical red bar). The fifth position 
of the alignment (red arrow) is suspected to distinguish hosts with “V” in 
L2HGDH in which the GlpO peptide would become immunogenic from 
non‑responsive hosts with “I” in L2HGDH. B) Predicted structure model 
of the GlpO from Escherichia coli (2QCU) (light blue secondary structure) 
aligned to the immunogenic peptide from ILRI181 (DICIIGGGIIG) in 
orange. Note that the location of this peptide is in close neighborhood to 
the FAD co‑factor (ball&stick model).
Additional file 2. Experimental challenge of goats with Mycoplasma 
capricolum subsp. capripneumoniae ILRI181. A) intranasal spray infec‑
tion; covering one nostril at the time, the infectious material (500 μL/nos‑
tril) was administered through a syringe fixed with an atomizer, B) place‑
ment of the needle, 5 to 10 cm distal to the larynx, for the transtracheal 
administration, C), injection of the Mycoplasma‑containing broth prior to 
flushing with sterile PBS. A successful administration was confirmed by 
subsequent coughing.
Additional file 3. Body temperature, respiratory rate and body 
weight dynamics. A: Clinical parameters measured from individual 
Mccp‑infected animals. Top panel: body temperature, the lower dotted 
line indicates fever (39.5 °C), the upper dotted line indicates high fever 
(40.5 °C); Middle panel: breathing frequency per minute, the dotted line 
indicates a high breathing frequency of 50/min; Bottom panel: weight 
change in kg throughout the trial. B: Clinical parameters measured from 
individual mock‑infected animals. Top panel: body temperature, the lower 
dotted line indicates fever (39.5 °C), the upper dotted line indicates high 
fever (40.5 °C); Middle panel: breathing frequency per minute, the dotted 
line indicates a high breathing frequency of 50/min; Bottom panel: weight 
change in kg throughout the trial.
Additional file 4. Haematological parameters measured from indi‑
vidual Mccp‑infected animals. A) white blood cell count  (103/μL), B) red 
blood cell count  (106/μL), C) haemoglobin levels (g/dl) and D) haematocrit 
(%).
Additional file 5. Macroscopic lesions observed during post‑mortem. 
A: thoracic cavity with yellow fibrin accumulated between the parietal 
and visceral pleura in the right lung, creating fibrinous adhesions between 
the lung and the chest wall; B: lung showing fibrinous pleuropneumonia 
with extended deposits of fibrin covering the pulmonary (right) surface; C: 
pneumonia affecting more than 60% of the right lung parenchyma (apical 
lobe, medium lobe and cranial part of diaphragmatic lobe); D: transverse 
section of lung, acute inflammation of the parenchyma with conges‑
tion and pulmonary edema; E: cut section of lung lobe with pneumonia. 
Parenchyma is firm showing areas varying from acute inflammation (red‑
dish) to necrosis (grayish); F: lung sequestra; necrotic tissue is surrounded 
by a white fibrotic capsule; G: enlarged and hemorrhagic respiratory 
lymph nodes (mediastinal and peribronchial); H: fibrinous pleural exudate 
collected from the thorax cavity of a single goat; I: kidney infarct, hemor‑
rhagic area is surrounded by a pale white zone.
Additional file 6. Serological responses against Mycoplasma capri‑
colum subsp. capripneumoniae measured by IDEXX CCPP Ab Test. A) 
Table displaying individual serological responses of Mccp‑infected animals. 
B) Antibody response (mean values) of euthanized vs surviving goats 
within the Mccp‑infected group. C) Table displaying individual serological 
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responses of mock‑infected animals. All values are expressed as % of 
inhibition. Cutoff = 55%. Positive ≥ 55%.
Additional file 7. In vivo detection of glycerol‑3‑phospate oxidase 
(GlpO, 42.6 kDa). Pleural fluid samples were separated by SDS‑PAGE and 
were transferred to nitrocellulose membranes for subsequent immuno‑
blot analysis using a polyclonal rabbit anti‑GlpO antibody. The right side 
contains the loading control of the samples that have been used in the 
immunoblot on the left side (Coomassie stain). Positive controls were the 
strains Mycoplasma capricolum subsp. capripneumoniae  F38T and ILRI181 
as well as Mycoplasma mycoides subsp. capri GM12 all expressing GlpO, 
negative controls were pleural fluids from animals CM189 and CM049 that 
contained very few Mycoplasma.
Additional file 8. Summary table of urine pH taken at necropsy. 
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